Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients

Giorgio A Medranda1, Toby Rogers1,2, Syed W Ali1

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Abstract

Insights

Prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement (TAVR) is rare in low-risk patients but leads to significant complications, including stroke and death. Further research is needed to minimize PVE incidence and improve patient outcomes following TAVR.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Prosthetic Valve Endocarditis Research

Background:

  • Prosthetic valve endocarditis (PVE) is a rare but serious complication following aortic valve replacement.
  • Limited data exists on PVE incidence and outcomes specifically in low-risk patients undergoing transcatheter aortic valve replacement (TAVR).

Purpose of the Study:

  • To investigate the incidence, causative organisms, clinical course, and outcomes of PVE in low-risk patients after TAVR.
  • To provide crucial data on PVE in a population where such information is currently lacking.

Main Methods:

  • A retrospective review of low-risk patients who underwent TAVR between 2016 and 2020 was conducted.
  • Patients with definitive PVE, as adjudicated by an independent Clinical Events Committee, were analyzed.

Main Results:

  • Out of 396 low-risk patients, 11 developed PVE at a median of 379 days post-TAVR. Incidence was 1.5% within the first year and 2.8% thereafter.
  • Streptococcus was the most common organism. Early PVE (≤365 days) was associated with embolic stroke and re-intervention, while late PVE (>365 days) also frequently caused embolic stroke.
  • Embolic stroke complicated the majority of PVE cases, leading to significant morbidity and mortality, including death, need for rehabilitation, or home care.

Conclusions:

  • Prosthetic valve endocarditis is infrequent but carries substantial morbidity and mortality risks after TAVR in low-risk individuals.
  • Embolic stroke is a major complication of PVE post-TAVR, significantly worsening patient outcomes.
  • Strategies to minimize PVE incidence following TAVR are essential to improve patient prognosis.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
72
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
51
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
91
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
49
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
49
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
74